Marie Curie MSCA PhD position in medical science

Arbetsbeskrivning

The University of Gothenburg tackles society's challenges with diverse knowledge. 37 000 students and 6 000 employees make the university a large and inspiring place to work and study. Strong research and attractive study programmes attract scientists and students from around the world. With new knowledge and new perspectives, the University contributes to a better future.

Arbetsplats: Sahlgrenska Academy

Titel: Marie Curie MSCA PhD position in medical science - Prediction of adverse events in anxiety

Reference number: UR 2017/193. Project title: Prediction of negative life outcomes in individuals with anxiety. Job assignments: Anxiety and anxiety symptoms has been linked to several adverse outcomes through life. Unfortunately, little is known about how to best identify individuals with anxiety symptoms that will be at greater risk for these adverse outcomes. Improved capacity to identify groups of individuals at greater risk could help the child and adolescent mental health services to decide who needs more intense monitoring, and ultimately improve the health and prognosis of these individuals. An increased prediction ability of high risk groups is aided by large datasets and detailed information on potential predictive variables. The Child and Adolescent Twin Study in Sweden (CATSS) is such a dataset, with follow up of a large number of individuals with regards to adverse outcomes in adolescence and young adulthood. The PhD-project will be based on data from CATSS - an ongoing prospective study that started in 2004, in which parents of all twins born in Sweden are contacted and asked to participate in a telephone interview in connection with their twins´ 9th birthday. The CATSS is also linked to several national register, among these the Medical Birth Register, The National Patient Register, the Prescribed drug Register and registers containing information about sick leave, disability pension, grades and court sentences. The project will have a longitudinal approach mending categorical and continuous phenotypic data with molecular genetic data in order to identify, delineate and describe groups of individuals with anxiety who might be particularly vulnerable to negative out comes in late adolescence/adulthood. The project is a part of Childhood and Adolescence Psychopathology: unravelling the complex etiology by a large Interdisciplinary Collaboration in Europe (CAPICE), a EU-financed Marie Sklodowska-Curie Initial Training Network. The PhD position comprises 4 years full-time studies and leads to a doctoral degree. The position is funded via doctoral studentship (MSCA financing).

To be admitted to third-cycle studies you must fulfill both the general and the specific entry requirements. The general entry requirements is fulfilled if you have: 1. completed a degree at a second-cycle level, or 2. completed at least 240 credits worth of studies of which at least 60 credits must be at a second-cycle level, or 3. acquired equivalent knowledge in some other way in Sweden or abroad. The specific entry requirements is fulfilled if you have completed the English B/6 course or is considered to have acquired equivalent knowledge through previous studies.

Additional information: In order to be approved for MSCA financing the applicant, at the time for the application, should not have resided in Sweden more than 12 months in the 3 years immediately prior to the reference date. Moreover the applicant must be in the first four years (full-time equivalent research experience) of their research careers and have not been awarded a doctoral degree.


Kontaktperson:
Funktion: Project supervisor
Namn: Sebastian Lundström, Institute of Neuroscience and Physiology
E-post: sebastian.lundstrom@neuro.gu.se

Telefon: +46 31 786 0000

Sammanfattning

Postadress

Universitetsplatsen 1
Göteborg, 40530

Liknande jobb


Drug Product Delivery Operator at AstraZeneca

Drug Product Delivery Operator at AstraZeneca

25 november 2024

Senior Scientist Pharmaceutical

Senior Scientist Pharmaceutical

21 november 2024

Scientist in Vivo

Scientist in Vivo

19 november 2024

19 november 2024